speb/financial-data huggingface dataset:
UBI.AX balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 7367853.00
UBI.AX balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 7367853.00
UBI.AX balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 3808229.00
UBI.AX balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 3808229.00
UBI.AX income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -16968464.00
UBI.AX income_statement (quarterly, 2024-12-31) — Total Operating Income As Reported: -4814582.00
UBI.AX income_statement (annual, 2024-12-31) — Total Other Finance Cost: 82277.00
UBI.AX income_statement (quarterly, 2024-12-31) — Total Other Finance Cost: 21541.00
UBI.AX income_statement (annual, 2024-12-31) — Total Unusual Items: -9539.00
UBI.AX income_statement (quarterly, 2024-12-31) — Total Unusual Items: 35039.00
UBI.AX income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -9539.00
UBI.AX income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 35039.00
UBI.AX balance_sheet (annual, 2024-12-31) — Work In Process: 611170.00
UBI.AX balance_sheet (quarterly, 2024-12-31) — Work In Process: 611170.00
UBI.AX balance_sheet (annual, 2024-12-31) — Working Capital: 13811809.00
UBI.AX balance_sheet (quarterly, 2024-12-31) — Working Capital: 13811809.00
UBI.AX income_statement (quarterly, 2025-03-31) — +Operating Expense: 4965076.00
UBI.AX income_statement (quarterly, 2025-03-31) — +Total Revenue: 1554659.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 684086.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 933054.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -28406819.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 131347039.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -424191.00
UBI.AX income_statement (quarterly, 2025-03-31) — Amortization: 43647.00
UBI.AX income_statement (quarterly, 2025-03-31) — Amortization Of Intangibles Income Statement: 43647.00
UBI.AX income_statement (quarterly, 2025-03-31) — Basic Average Shares: 298067435.00
UBI.AX income_statement (quarterly, 2025-03-31) — Basic EPS: -0.01
UBI.AX cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 8899105.00
UBI.AX cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -30622.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 3092390.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Capital Stock: 29807.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 4561315.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 4561315.00
UBI.AX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -237588.00
UBI.AX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -30622.00
UBI.AX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -3719264.00
UBI.AX cash_flow (quarterly, 2025-03-31) — Change In Inventory: -384987.00
UBI.AX cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 71330.00
UBI.AX cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 643395.00
UBI.AX cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -337055.00
UBI.AX cash_flow (quarterly, 2025-03-31) — Change In Receivables: 23447.00
UBI.AX cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 16130.00
UBI.AX cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 23447.00
UBI.AX cash_flow (quarterly, 2025-03-31) — Changes In Cash: -3987474.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Common Stock: 29807.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 13527752.00
UBI.AX cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
UBI.AX income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 711315.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 2182891.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Current Assets: 15188718.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 766806.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Current Debt: 462006.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1228812.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 12193.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 12193.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 5084092.00
UBI.AX cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 163210.00
UBI.AX income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 150643.00
UBI.AX cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 163210.00
UBI.AX income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 150643.00
UBI.AX income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 106996.00
UBI.AX income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 298067435.00
UBI.AX income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.01
UBI.AX income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -3837950.00
UBI.AX income_statement (quarterly, 2025-03-31) — EBIT: -3835714.00
UBI.AX income_statement (quarterly, 2025-03-31) — EBITDA: -3672504.00
UBI.AX cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 4684.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 94050.00
UBI.AX cash_flow (quarterly, 2025-03-31) — End Cash Position: 4916315.00
UBI.AX cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -237588.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Finished Goods: 6079600.00
UBI.AX cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -3749886.00
UBI.AX income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 167295.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -351054.00
UBI.AX income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 4073494.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 1357245.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Gross PPE: 35155820.00
UBI.AX income_statement (quarterly, 2025-03-31) — Gross Profit: 843344.00
UBI.AX income_statement (quarterly, 2025-03-31) — Insurance And Claims: 163927.00
UBI.AX income_statement (quarterly, 2025-03-31) — Interest Expense: 2236.00
UBI.AX income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 2236.00
UBI.AX income_statement (quarterly, 2025-03-31) — Interest Income: 63391.00
UBI.AX income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 63391.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Inventories Adjustments Allowances: -971698.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Inventory: 5970853.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Invested Capital: 13989758.00
UBI.AX cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -30622.00
UBI.AX cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Leases: 9342752.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Line Of Credit: 462006.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 2325584.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 2325584.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 1319277.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 23378550.00
UBI.AX cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
UBI.AX cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -9537.00
UBI.AX income_statement (quarterly, 2025-03-31) — Net Income: -3837950.00
UBI.AX income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -3837950.00
UBI.AX income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -3837950.00
UBI.AX income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -3837950.00
UBI.AX income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -3837950.00
UBI.AX cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -3837950.00
UBI.AX income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -3837950.00
UBI.AX income_statement (quarterly, 2025-03-31) — Net Interest Income: 38411.00
UBI.AX cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -237588.00
UBI.AX income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 38411.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Net PPE: 6749001.00
UBI.AX cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -30622.00
UBI.AX cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: -237588.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 13527752.00
UBI.AX income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -3839799.00
UBI.AX income_statement (quarterly, 2025-03-31) — Normalized Income: -4005245.00
UBI.AX cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -3719264.00
UBI.AX cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -9537.00
UBI.AX income_statement (quarterly, 2025-03-31) — Operating Income: -4121732.00
UBI.AX income_statement (quarterly, 2025-03-31) — Operating Revenue: 1554659.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 298067435.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 258597.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -351054.00
UBI.AX income_statement (quarterly, 2025-03-31) — Other Gand A: 1101171.00
UBI.AX income_statement (quarterly, 2025-03-31) — Other Income Expense: 245371.00
UBI.AX cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -51117.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 413036.00
UBI.AX income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 78076.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Other Properties: 2434518.00
UBI.AX income_statement (quarterly, 2025-03-31) — Other Taxes: -346044.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Payables: 684086.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 2866977.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 976110.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 895653.00
UBI.AX income_statement (quarterly, 2025-03-31) — Pretax Income: -3837950.00
UBI.AX cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 0.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
UBI.AX income_statement (quarterly, 2025-03-31) — Provision For Doubtful Accounts: 21832.00
UBI.AX cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -30622.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Raw Materials: 505965.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Receivables: 3467300.00
UBI.AX income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 698748.00
UBI.AX income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 163210.00
UBI.AX income_statement (quarterly, 2025-03-31) — Rent And Landing Fees: 143248.00
UBI.AX income_statement (quarterly, 2025-03-31) — Rent Expense Supplemental: 143248.00
UBI.AX cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -237588.00
UBI.AX income_statement (quarterly, 2025-03-31) — Research And Development: 795503.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 35000.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -117498040.00
UBI.AX income_statement (quarterly, 2025-03-31) — Salaries And Wages: 2665148.00
UBI.AX income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 269648.00
UBI.AX income_statement (quarterly, 2025-03-31) — Selling General And Administration: 4343142.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Share Issued: 298067435.00
UBI.AX cash_flow (quarterly, 2025-03-31) — Short Term Debt Payments: -237588.00
UBI.AX cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 0.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 13527752.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 13527752.00
UBI.AX income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
UBI.AX income_statement (quarterly, 2025-03-31) — Tax Provision: 0.00
UBI.AX income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 2534246.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Total Assets: 22350755.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 13527752.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Total Debt: 3554396.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 13527752.00
UBI.AX income_statement (quarterly, 2025-03-31) — Total Expenses: 5676391.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 8823003.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 7162037.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 3738911.00
UBI.AX income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -4467776.00
UBI.AX income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: 22744.00
UBI.AX income_statement (quarterly, 2025-03-31) — Total Unusual Items: 167295.00
UBI.AX income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 167295.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Work In Process: 356986.00
UBI.AX balance_sheet (quarterly, 2025-03-31) — Working Capital: 10104626.00
UBI.AX income_statement (quarterly, 2025-06-30) — +Operating Expense: 5134146.00
UBI.AX income_statement (quarterly, 2025-06-30) — +Total Revenue: 1208764.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1413584.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 722609.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -28535810.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 131362812.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -130134.00
UBI.AX income_statement (quarterly, 2025-06-30) — Amortization: 43647.00
UBI.AX income_statement (quarterly, 2025-06-30) — Amortization Of Intangibles Income Statement: 43647.00
UBI.AX income_statement (quarterly, 2025-06-30) — Basic Average Shares: 298067435.00
UBI.AX income_statement (quarterly, 2025-06-30) — Basic EPS: -0.02
UBI.AX cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 4916315.00
UBI.AX cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -8496.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 2838473.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 29807.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 2198490.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 2198490.00
UBI.AX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -254125.00
UBI.AX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -8496.00
UBI.AX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -2127524.00
UBI.AX cash_flow (quarterly, 2025-06-30) — Change In Inventory: 2694042.00
UBI.AX cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -59602.00
UBI.AX cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -454861.00
UBI.AX cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 1928993.00
UBI.AX cash_flow (quarterly, 2025-06-30) — Change In Receivables: 210445.00
UBI.AX cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 4319017.00
UBI.AX cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 210445.00
UBI.AX cash_flow (quarterly, 2025-06-30) — Changes In Cash: -2390145.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Common Stock: 29807.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 7079156.00
UBI.AX cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
UBI.AX income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 2415458.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 1030665.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Current Assets: 8036795.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 618528.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Current Debt: 207880.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 826408.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 10057.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 10057.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 4230985.00
UBI.AX cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 162200.00
UBI.AX income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 174767.00
UBI.AX cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 162200.00
UBI.AX income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 174767.00
UBI.AX income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 131120.00
UBI.AX income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 298067435.00
UBI.AX income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.02
UBI.AX income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -6610674.00
UBI.AX income_statement (quarterly, 2025-06-30) — EBIT: -6610167.00
UBI.AX income_statement (quarterly, 2025-06-30) — EBITDA: -6435400.00
UBI.AX cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 27320.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 67701.00
UBI.AX cash_flow (quarterly, 2025-06-30) — End Cash Position: 2553490.00
UBI.AX cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -254125.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Finished Goods: 4591158.00
UBI.AX cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -2136020.00
UBI.AX income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -276652.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -204749.00
UBI.AX income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 2718807.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 852743.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Gross PPE: 35026831.00
UBI.AX income_statement (quarterly, 2025-06-30) — Gross Profit: -1206694.00
UBI.AX income_statement (quarterly, 2025-06-30) — Insurance And Claims: 25364.00
UBI.AX income_statement (quarterly, 2025-06-30) — Interest Expense: 507.00
UBI.AX income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 507.00
UBI.AX income_statement (quarterly, 2025-06-30) — Interest Income: 16458.00
UBI.AX income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 16458.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Inventories Adjustments Allowances: -2248401.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Inventory: 3276811.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Invested Capital: 7287036.00
UBI.AX cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -8496.00
UBI.AX cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Leases: 9342469.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Line Of Credit: 207880.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 2219945.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 2219945.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 1342020.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 23351411.00
UBI.AX cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
UBI.AX cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: 122737.00
UBI.AX income_statement (quarterly, 2025-06-30) — Net Income: -6610674.00
UBI.AX income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -6610674.00
UBI.AX income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -6610674.00
UBI.AX income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -6610674.00
UBI.AX income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -6610674.00
UBI.AX cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -6610674.00
UBI.AX income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -6610674.00
UBI.AX income_statement (quarterly, 2025-06-30) — Net Interest Income: -6793.00
UBI.AX cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -254125.00
UBI.AX income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -6793.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Net PPE: 6491021.00
UBI.AX cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -8496.00
UBI.AX cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: -254125.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 7079156.00
UBI.AX income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -6158748.00
UBI.AX income_statement (quarterly, 2025-06-30) — Normalized Income: -6334022.00
UBI.AX cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -2127524.00
UBI.AX cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 122737.00
UBI.AX income_statement (quarterly, 2025-06-30) — Operating Income: -6340840.00
UBI.AX income_statement (quarterly, 2025-06-30) — Operating Revenue: 1208764.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 298067435.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 230411.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -204749.00
UBI.AX income_statement (quarterly, 2025-06-30) — Other Gand A: 349111.00
UBI.AX income_statement (quarterly, 2025-06-30) — Other Income Expense: -263041.00
UBI.AX cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -136577.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 411991.00
UBI.AX income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 13611.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Other Properties: 2332951.00
UBI.AX income_statement (quarterly, 2025-06-30) — Other Taxes: -363722.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Payables: 1413584.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 2444249.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 950271.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 881386.00
UBI.AX income_statement (quarterly, 2025-06-30) — Pretax Income: -6610674.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
UBI.AX income_statement (quarterly, 2025-06-30) — Provision For Doubtful Accounts: 77345.00
UBI.AX cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -8496.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Raw Materials: 432855.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Receivables: 1414697.00
UBI.AX income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 2428025.00
UBI.AX income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 162200.00
UBI.AX income_statement (quarterly, 2025-06-30) — Rent And Landing Fees: 92701.00
UBI.AX income_statement (quarterly, 2025-06-30) — Rent Expense Supplemental: 92701.00
UBI.AX cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -254125.00
UBI.AX income_statement (quarterly, 2025-06-30) — Research And Development: 2019167.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 35000.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -124108714.00
UBI.AX income_statement (quarterly, 2025-06-30) — Salaries And Wages: 2251631.00
UBI.AX income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 507782.00
UBI.AX income_statement (quarterly, 2025-06-30) — Selling General And Administration: 3226589.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Share Issued: 298067435.00
UBI.AX cash_flow (quarterly, 2025-06-30) — Short Term Debt Payments: -254125.00
UBI.AX cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 15773.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 7079156.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 7079156.00
UBI.AX income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
UBI.AX income_statement (quarterly, 2025-06-30) — Tax Provision: 0.00
UBI.AX income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 692088.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Total Assets: 14939807.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 7079156.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Total Debt: 3046353.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 7079156.00
UBI.AX income_statement (quarterly, 2025-06-30) — Total Expenses: 7549604.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 7860651.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 6903012.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 3629666.00
UBI.AX income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -6704562.00
UBI.AX income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: 22744.00
UBI.AX income_statement (quarterly, 2025-06-30) — Total Unusual Items: -276652.00
UBI.AX income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -276652.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Work In Process: 501199.00
UBI.AX balance_sheet (quarterly, 2025-06-30) — Working Capital: 3805810.00
UBI.PA balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -328800000.00
UBI.PA balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -2200000.00
UBI.PA balance_sheet (annual, 2022-03-31) — Available For Sale Securities: 42800000.00
UBI.PA balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 46000000.00
UBI.PA balance_sheet (annual, 2022-03-31) — Capital Lease Obligations: 334900000.00
UBI.PA balance_sheet (annual, 2022-03-31) — Cash Equivalents: 199000000.00
UBI.PA balance_sheet (annual, 2022-03-31) — Cash Financial: 1253600000.00
UBI.PA cash_flow (annual, 2022-03-31) — Common Stock Payments: -117000000.00
UBI.PA balance_sheet (annual, 2022-03-31) — Construction In Progress: 9500000.00
UBI.PA balance_sheet (annual, 2022-03-31) — Current Capital Lease Obligation: 48500000.00
UBI.PA balance_sheet (annual, 2022-03-31) — Current Debt: 601400000.00
UBI.PA balance_sheet (annual, 2022-03-31) — Current Deferred Assets: 40700000.00
UBI.PA balance_sheet (annual, 2022-03-31) — Derivative Product Liabilities: 0.00
UBI.PA balance_sheet (annual, 2022-03-31) — Finished Goods: 22200000.00
UBI.PA cash_flow (annual, 2022-03-31) — Gain Loss On Investment Securities: 200000.00
UBI.PA balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 473200000.00
UBI.PA balance_sheet (annual, 2022-03-31) — Hedging Assets Current: 700000.00
UBI.PA income_statement (annual, 2022-03-31) — Impairment Of Capital Assets: 8500000.00
UBI.PA income_statement (annual, 2022-03-31) — Interest Income: 1500000.00
UBI.PA income_statement (annual, 2022-03-31) — Interest Income Non Operating: 1500000.00
UBI.PA balance_sheet (annual, 2022-03-31) — Inventories Adjustments Allowances: -6200000.00
UBI.PA balance_sheet (annual, 2022-03-31) — Investmentsin Associatesat Cost: 0.00
UBI.PA balance_sheet (annual, 2022-03-31) — Land And Improvements: 5100000.00
UBI.PA balance_sheet (annual, 2022-03-31) — Long Term Capital Lease Obligation: 286400000.00
UBI.PA balance_sheet (annual, 2022-03-31) — Long Term Debt: 1133900000.00
UBI.PA balance_sheet (annual, 2022-03-31) — Long Term Equity Investment: 0.00
UBI.PA balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 363000000.00
UBI.PA cash_flow (annual, 2022-03-31) — Net Business Purchase And Sale: -26500000.00
UBI.PA balance_sheet (annual, 2022-03-31) — Net Debt: 282800000.00
UBI.PA cash_flow (annual, 2022-03-31) — Net Other Financing Charges: 239900000.00
UBI.PA cash_flow (annual, 2022-03-31) — Net Other Investing Changes: -26400000.00
UBI.PA cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: -67000000.00
UBI.PA balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 9300000.00
UBI.PA cash_flow (annual, 2022-03-31) — Other Cash Adjustment Outside Changein Cash: 100000.00
UBI.PA balance_sheet (annual, 2022-03-31) — Other Current Assets: 200000.00
UBI.PA balance_sheet (annual, 2022-03-31) — Other Equity Interest: 100000.00
UBI.PA balance_sheet (annual, 2022-03-31) — Other Properties: 112800000.00
UBI.PA balance_sheet (annual, 2022-03-31) — Other Short Term Investments: 800000.00
UBI.PA balance_sheet (annual, 2022-03-31) — Prepaid Assets: 45600000.00
UBI.PA balance_sheet (annual, 2022-03-31) — Properties: 0.00
UBI.PA cash_flow (annual, 2022-03-31) — Purchase Of PPE: -67000000.00
UBI.PA cash_flow (annual, 2022-03-31) — Repurchase Of Capital Stock: -117000000.00
UBI.PA income_statement (annual, 2022-03-31) — Special Income Charges: -98600000.00
UBI.PA income_statement (annual, 2022-03-31) — Total Operating Income As Reported: 241500000.00
UBI.PA income_statement (annual, 2022-03-31) — Total Unusual Items: -8500000.00
UBI.PA income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: -98600000.00
UBI.PA balance_sheet (annual, 2022-03-31) — Treasury Shares Number: 2449019.00
UBI.PA income_statement (annual, 2023-03-31) — +Operating Expense: 2124600000.00
UBI.PA income_statement (annual, 2023-03-31) — +Total Revenue: 1814300000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Accounts Payable: 123100000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Accounts Receivable: 268300000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -367100000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 630200000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -1300000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 44500000.00
UBI.PA income_statement (annual, 2023-03-31) — Basic Average Shares: 121127451.00
UBI.PA income_statement (annual, 2023-03-31) — Basic EPS: -4.08
UBI.PA cash_flow (annual, 2023-03-31) — Beginning Cash Position: 1391400000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 43900000.00
UBI.PA cash_flow (annual, 2023-03-31) — Capital Expenditure: -1070300000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 309000000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Capital Stock: 9700000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 1490900000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 1490900000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Cash Equivalents: 87300000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Cash Financial: 1403600000.00
UBI.PA cash_flow (annual, 2023-03-31) — Change In Inventory: -2600000.00
UBI.PA cash_flow (annual, 2023-03-31) — Change In Other Current Assets: -135100000.00
UBI.PA cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: -45100000.00
UBI.PA cash_flow (annual, 2023-03-31) — Change In Payable: -22800000.00
UBI.PA cash_flow (annual, 2023-03-31) — Change In Receivables: 210900000.00
UBI.PA cash_flow (annual, 2023-03-31) — Change In Working Capital: 5300000.00
UBI.PA cash_flow (annual, 2023-03-31) — Changes In Cash: 126600000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Common Stock: 9700000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Common Stock Equity: 1479200000.00
UBI.PA cash_flow (annual, 2023-03-31) — Common Stock Issuance: 100400000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Construction In Progress: 6100000.00
UBI.PA income_statement (annual, 2023-03-31) — Cost Of Revenue: 216600000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Current Assets: 2056000000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 45300000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Current Debt: 91400000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 136700000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Current Deferred Assets: 48300000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Current Liabilities: 738900000.00
UBI.PA cash_flow (annual, 2023-03-31) — Deferred Tax: -109100000.00
UBI.PA cash_flow (annual, 2023-03-31) — Depreciation: 1287100000.00
UBI.PA cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 1287100000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Derivative Product Liabilities: 0.00
UBI.PA income_statement (annual, 2023-03-31) — Diluted Average Shares: 121127451.00
UBI.PA income_statement (annual, 2023-03-31) — Diluted EPS: -4.08
UBI.PA income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: -494200000.00
UBI.PA income_statement (annual, 2023-03-31) — EBIT: -567800000.00
UBI.PA income_statement (annual, 2023-03-31) — EBITDA: 719300000.00
UBI.PA cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: -53400000.00
UBI.PA cash_flow (annual, 2023-03-31) — End Cash Position: 1464600000.00
UBI.PA cash_flow (annual, 2023-03-31) — Financing Cash Flow: 543600000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Finished Goods: 18500000.00
UBI.PA cash_flow (annual, 2023-03-31) — Free Cash Flow: -380700000.00
UBI.PA cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: 600000.00
UBI.PA income_statement (annual, 2023-03-31) — General And Administrative Expense: 301500000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Goodwill: 73200000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 2121300000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 269600000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Gross PPE: 554800000.00
UBI.PA income_statement (annual, 2023-03-31) — Gross Profit: 1597800000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Hedging Assets Current: 700000.00
UBI.PA income_statement (annual, 2023-03-31) — Impairment Of Capital Assets: -600000.00
UBI.PA income_statement (annual, 2023-03-31) — Interest Expense: 36000000.00
UBI.PA income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 36000000.00
UBI.PA income_statement (annual, 2023-03-31) — Interest Income: 12500000.00
UBI.PA income_statement (annual, 2023-03-31) — Interest Income Non Operating: 12500000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Inventories Adjustments Allowances: -13600000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Inventory: 18500000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Invested Capital: 3632200000.00
UBI.PA cash_flow (annual, 2023-03-31) — Investing Cash Flow: -1106600000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 44500000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Investmentsin Associatesat Cost: 0.00
UBI.PA cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 100400000.00
UBI.PA cash_flow (annual, 2023-03-31) — Issuance Of Debt: 1437300000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Land And Improvements: 5000000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 263700000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Long Term Debt: 2061600000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 2325300000.00
UBI.PA cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 1437300000.00
UBI.PA cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -949100000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 0.00
UBI.PA balance_sheet (annual, 2023-03-31) — Long Term Provisions: 20900000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 499800000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Minority Interest: 3500000.00
UBI.PA income_statement (annual, 2023-03-31) — Minority Interests: 600000.00
UBI.PA cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: -30800000.00
UBI.PA cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 100400000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Net Debt: 662100000.00
UBI.PA income_statement (annual, 2023-03-31) — Net Income: -494200000.00
UBI.PA income_statement (annual, 2023-03-31) — Net Income Common Stockholders: -494200000.00
UBI.PA income_statement (annual, 2023-03-31) — Net Income Continuous Operations: -494700000.00
UBI.PA income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: -494200000.00
UBI.PA income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: -494200000.00
UBI.PA cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: -494700000.00
UBI.PA income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: -494700000.00
UBI.PA cash_flow (annual, 2023-03-31) — Net Intangibles Purchase And Sale: -1022000000.00
UBI.PA income_statement (annual, 2023-03-31) — Net Interest Income: -22500000.00
UBI.PA cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -51400000.00
UBI.PA cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 488200000.00
UBI.PA cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 488200000.00
UBI.PA income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -22500000.00
UBI.PA cash_flow (annual, 2023-03-31) — Net Other Investing Changes: -30800000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Net PPE: 187700000.00
UBI.PA cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -48200000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Net Tangible Assets: -642100000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 252000000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 69500000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 17100000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 8800000.00
UBI.PA income_statement (annual, 2023-03-31) — Normalized EBITDA: 718700000.00
UBI.PA income_statement (annual, 2023-03-31) — Normalized Income: -386442580.32
UBI.PA cash_flow (annual, 2023-03-31) — Operating Cash Flow: 689600000.00
UBI.PA income_statement (annual, 2023-03-31) — Operating Income: -526800000.00
UBI.PA income_statement (annual, 2023-03-31) — Operating Revenue: 1814300000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 125105117.00
UBI.PA cash_flow (annual, 2023-03-31) — Other Cash Adjustment Outside Changein Cash: 100000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 214500000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Other Equity Interest: 100000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 2048100000.00
UBI.PA cash_flow (annual, 2023-03-31) — Other Non Cash Items: -4100000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 300000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 16400000.00
UBI.PA income_statement (annual, 2023-03-31) — Other Operating Expenses: 44100000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Other Properties: 112600000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Other Receivables: 63800000.00
UBI.PA income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
UBI.PA balance_sheet (annual, 2023-03-31) — Payables: 191900000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Prepaid Assets: 50600000.00
UBI.PA income_statement (annual, 2023-03-31) — Pretax Income: -603800000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Properties: 0.00
UBI.PA cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 21700000.00
UBI.PA cash_flow (annual, 2023-03-31) — Purchase Of Intangibles: -1022100000.00
UBI.PA cash_flow (annual, 2023-03-31) — Purchase Of Investment: -51400000.00
UBI.PA cash_flow (annual, 2023-03-31) — Purchase Of PPE: -48200000.00
UBI.PA income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 216600000.00
UBI.PA income_statement (annual, 2023-03-31) — Reconciled Depreciation: 1287100000.00
UBI.PA cash_flow (annual, 2023-03-31) — Repayment Of Debt: -949100000.00
UBI.PA income_statement (annual, 2023-03-31) — Research And Development: 1440400000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Retained Earnings: -494200000.00
UBI.PA cash_flow (annual, 2023-03-31) — Sale Of Intangibles: 100000.00
UBI.PA income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 343200000.00
UBI.PA income_statement (annual, 2023-03-31) — Selling General And Administration: 644700000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Share Issued: 125520452.00
UBI.PA income_statement (annual, 2023-03-31) — Special Income Charges: -58900000.00
UBI.PA cash_flow (annual, 2023-03-31) — Stock Based Compensation: 62000000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Stockholders Equity: 1479200000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Tangible Book Value: -642100000.00
UBI.PA income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: -10642580.32
UBI.PA income_statement (annual, 2023-03-31) — Tax Provision: -109100000.00
UBI.PA income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.18
UBI.PA balance_sheet (annual, 2023-03-31) — Taxes Receivable: 163200000.00
UBI.PA cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -79100000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Total Assets: 4670800000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Total Capitalization: 3540800000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Total Debt: 2462000000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 1482700000.00
UBI.PA income_statement (annual, 2023-03-31) — Total Expenses: 2341200000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 3188100000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 2614900000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 2449200000.00
UBI.PA income_statement (annual, 2023-03-31) — Total Operating Income As Reported: -585800000.00
UBI.PA income_statement (annual, 2023-03-31) — Total Other Finance Cost: -1000000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Total Tax Payable: 68800000.00
UBI.PA income_statement (annual, 2023-03-31) — Total Unusual Items: 600000.00
UBI.PA income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -58900000.00
UBI.PA balance_sheet (annual, 2023-03-31) — Treasury Shares Number: 415335.00
UBI.PA balance_sheet (annual, 2023-03-31) — Working Capital: 1317100000.00
UBI.PA income_statement (annual, 2024-03-31) — +Operating Expense: 1782900000.00
UBI.PA income_statement (annual, 2024-03-31) — +Total Revenue: 2300900000.00
UBI.PA balance_sheet (annual, 2024-03-31) — Accounts Payable: 157100000.00
UBI.PA balance_sheet (annual, 2024-03-31) — Accounts Receivable: 746200000.00
UBI.PA balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -309900000.00
UBI.PA balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 675000000.00
UBI.PA balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -5300000.00
UBI.PA cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 677600000.00
UBI.PA balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 41000000.00
UBI.PA income_statement (annual, 2024-03-31) — Basic Average Shares: 124251969.00
UBI.PA income_statement (annual, 2024-03-31) — Basic EPS: 1.27
UBI.PA cash_flow (annual, 2024-03-31) — Beginning Cash Position: 1464600000.00
UBI.PA balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 43300000.00
UBI.PA cash_flow (annual, 2024-03-31) — Capital Expenditure: -116200000.00
UBI.PA balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 319100000.00
UBI.PA balance_sheet (annual, 2024-03-31) — Capital Stock: 9900000.00
UBI.PA balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 1205200000.00
UBI.PA balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 1205200000.00
UBI.PA balance_sheet (annual, 2024-03-31) — Cash Equivalents: 81100000.00
UBI.PA balance_sheet (annual, 2024-03-31) — Cash Financial: 1124100000.00
UBI.PA cash_flow (annual, 2024-03-31) — Change In Inventory: 20000000.00
UBI.PA cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -44600000.00
UBI.PA cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 700000.00
UBI.PA cash_flow (annual, 2024-03-31) — Change In Payable: 39000000.00
UBI.PA cash_flow (annual, 2024-03-31) — Change In Receivables: -499300000.00
UBI.PA cash_flow (annual, 2024-03-31) — Change In Working Capital: -484200000.00
UBI.PA cash_flow (annual, 2024-03-31) — Changes In Cash: -265200000.00
UBI.PA balance_sheet (annual, 2024-03-31) — Common Stock: 9900000.00
UBI.PA balance_sheet (annual, 2024-03-31) — Common Stock Equity: 1876600000.00
UBI.PA cash_flow (annual, 2024-03-31) — Common Stock Issuance: 56400000.00
UBI.PA balance_sheet (annual, 2024-03-31) — Construction In Progress: 8500000.00
UBI.PA income_statement (annual, 2024-03-31) — Cost Of Revenue: 204200000.00
UBI.PA balance_sheet (annual, 2024-03-31) — Current Assets: 2292700000.00
UBI.PA balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 43400000.00
UBI.PA balance_sheet (annual, 2024-03-31) — Current Debt: 383600000.00
UBI.PA balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 427000000.00
UBI.PA balance_sheet (annual, 2024-03-31) — Current Liabilities: 1057500000.00
UBI.PA cash_flow (annual, 2024-03-31) — Deferred Tax: 96800000.00
UBI.PA cash_flow (annual, 2024-03-31) — Depreciation: 776100000.00
UBI.PA cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 776100000.00
UBI.PA balance_sheet (annual, 2024-03-31) — Derivative Product Liabilities: 0.00
UBI.PA income_statement (annual, 2024-03-31) — Diluted Average Shares: 127258065.00
UBI.PA income_statement (annual, 2024-03-31) — Diluted EPS: 1.24
UBI.PA income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 157800000.00
UBI.PA income_statement (annual, 2024-03-31) — EBIT: 329400000.00
UBI.PA income_statement (annual, 2024-03-31) — EBITDA: 1105500000.00
UBI.PA cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: 3100000.00
UBI.PA cash_flow (annual, 2024-03-31) — End Cash Position: 1202400000.00
UBI.PA cash_flow (annual, 2024-03-31) — Financing Cash Flow: 248700000.00
UBI.PA balance_sheet (annual, 2024-03-31) — Finished Goods: 8800000.00
UBI.PA cash_flow (annual, 2024-03-31) — Free Cash Flow: -509500000.00
UBI.PA cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: 500000.00
UBI.PA income_statement (annual, 2024-03-31) — General And Administrative Expense: 291100000.00
UBI.PA balance_sheet (annual, 2024-03-31) — Goodwill: 73300000.00
UBI.PA balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 2427000000.00
UBI.PA balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 751500000.00
UBI.PA balance_sheet (annual, 2024-03-31) — Gross PPE: 474300000.00
UBI.PA income_statement (annual, 2024-03-31) — Gross Profit: 2096700000.00